Charité 3R cordially invites you to a lecture on patient-derived organoids on the 11.10.2023 from 3:00-4:30 p.m. at Campus CVK, Berlin (Forschungshaus, ground floor, lecture hall 4), presented by two outstanding experts in the field.
- REGISTER HERE until 04.10.2023!
After the lectures, there will be the opportunity to discuss with both speakers in a get-together with drinks and food from 4:30 pm on.
- Hugo Snippert, University Medical Utrecht: Heterogeneity in tumors: a real-time and single-cell perspective
- Ulrich Keilholz, Charité, director of Charité Comprehensive Cancer Center, speaker of NCT Berlin: tba
Hugo Snippert is a group leader at the Centre for Molecular Medicine at UMC Utrecht, an ERC starting grant holder and a member of the Oncode institute. His group “Functional heterogeneity in cancer” uses patient derived (cancer) organoids to study cell fate decisions. Hugo Snippert and his team are applying high-content microscopy to follow the trajectory of stem cells and to study the transition from benign to early-onset malignant tumors in intestine organoids. He established a protocol that integrates 3D live-cell imaging and whole-genome sequencing of patient derived organoids (PDOs) to reconstruct tumor evolution. He has an interest in the underlying mechanisms of colorectal cancer metastasizing to the liver.